Prospective multicenter observational the personalized therapy with clopidogrel for stenting in acute coronary syndrome regarding the genetic polymorphisms (PROTOCOL) study

• Main Authors: G. I. Lifshits (Author), K. A. Apartsin (Author)
• פורמט: ספר
• יצא לאור: Izdatelstvo OKI, 2018-05-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Clopidogrel remains the main antiplatelet therapy drug for patients after coronary stenting (CS) due to acute coronary syndrome (ACS). The paper contains substantiation and design of an observatory study with the purpose to test the hypothesis that high frequency of of cytochrome CYP2d9*2 polymorphi...